Evidence map›Paper›PMID 10569759›Full record

ArticleInfection and immunity1999

Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.

J E Galen, J Nair, J Y Wang, S S Wasserman, M K Tanner, M B Sztein, M M Levine

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Genetic engineering ofEcoSal Plus · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. mBio · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J E GalenCenter for Vaccine Development, Division of Geographic Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. jgalen@umppa1.ab.umd.edu
J Nair
J Y Wang
S S Wasserman
M K Tanner
M B Sztein
M M Levine
University of Maryland, Baltimore · US

Funding

RECOMBINANT &LIVE ORAL SALMONELLA TYPHI HYBRID VACCINESR01AI029471 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 1990 to 2008
$3.7M
MULTIVALENT SALMONELLA TYPHI BASED MALARIA VACCINESR01AI040297 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 1997 to 2004
$1.8M
CONTROL MESURES IN AGING AND INFECTIOUS DISEASEN01AI045251 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 1994 to 2000
–
NIAID NIH HHS 5R01AI29471NIAID NIH HHS N01AI45251NIAID NIH HHS R01 AI029471NIAID NIH HHS R01 AI040297NIAID NIH HHS R01AI40297
6 · The paper itself

Abstract

The broad objective of the research presented here is to develop a noncatalytic plasmid maintenance system for the stabilization of multicopy expression plasmids encoding foreign antigens in a Salmonella typhi live-vector vaccine strain such as CVD 908-htrA. We have enhanced the maintenance of expression plasmids at two independent levels. First, we removed dependence upon balanced-lethal maintenance systems that involve catalytic enzymes expressed from multicopy plasmids; we accomplished this through incorporation into expression plasmids of a postsegregational killing system based on the noncatalytic hok-sok plasmid addiction system from the antibiotic resistance factor pR1. We also included at least one naturally occurring plasmid partition function in our expression plasmids, which eliminates random segregation of these plasmids, thereby enhancing their inheritance and stability; to accomplish this, we incorporated either the par locus from pSC101, the parA locus from pR1, or both. We monitored the stability of optimized expression plasmids within CVD 908-htrA by quantitating expression of a variant of green fluorescent protein (GFPuv) by using flow cytometry. In this report, we demonstrate the utility of this novel plasmid maintenance system in enhancing the stability of our expression plasmids and go on to show that as the copy number of stabilized plasmids increases, the toxicity of GFPuv synthesis also increases. The implications of these observations for the rational design of immunogenic and protective bacterial live vector vaccines are discussed.

Indexed as

Antigens, BacterialBacterial VaccinesFlow CytometryGenetic VectorsGreen Fluorescent ProteinsLuminescent ProteinsPlasmidsReplication OriginSalmonella typhiVaccines, AttenuatedVaccines, SyntheticAntigens, BacterialBacterial VaccinesGreen Fluorescent ProteinsLuminescent ProteinsVaccines, AttenuatedVaccines, Synthetic

Identifiers

PMID10569759
PMCPMC97051
OpenAlexW2120921897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.